These services may or may not be covered by all HealthPartners plans. Please see your plan documents for your own coverage information. If there is a difference between this general information and your plan documents, your plan documents will be used to determine your coverage.
Prior authorization is required for thoracic sympathectomy.
Prior authorization is required for botulinum toxins (Botox) – Pharmacy review is required. See associated policies in Related Content section of this page.
Prior authorization is not required for iontophoresis when performed in a provider’s office. Home iontophoresis units are not covered. See the Durable Medical Equipment (DME) benefits grid for additional information.
Thoracic sympathectomy for treatment of primary focal hyperhidrosis is generally covered subject to the indications listed below and per your plan documents.
Thoracic sympathectomy (open or endoscopic) for the treatment of primary focal hyperhidrosis is limited to a subset of patients with primary axillary or palmar hyperhidrosis that is severe intractable and disabling, as demonstrated by clinical documentation which indicates all of the following:
- The condition significantly interferes with the member’s ability to perform age-appropriate activities of daily living.
- The primary focal hyperhidrosis is causing a chronic dermatological complication such as skin maceration (softening due to exposure to moisture) with secondary infection, dermatitis/fungal conditions or other skin diseases.
- There is documented failure, contraindication or intolerance to treatment with medical therapies including:
- Topical and/or systemic medications such as prescription aluminum chloride or other extra strength antiperspirants, oral anticholinergics, beta-blockers, or benzodiazepines; and
- Treatment with Botulinum Toxin (Botox). Note: Botox is subject to separate pharmacy review. See associated policies in the Related Content section of this page.
- The following treatments or procedures are considered investigational:
- Sympathectomy for craniofacial or plantar hyperhidrosis
- Sympathectomy for secondary hyperhidrosis
- Tumenescent or ultrasonic liposuction and curettage for axillary hyperhidrosis
- Microwave energy therapy (e.g. miraDry)
- Sympathectomy when performed for conditions that are cosmetic in nature, such as excessive spontaneous facial blushing.
Thoracic sympathectomy for treatment of hyperhidrosis involves cutting and sealing a part of the sympathetic nerve chain that is located along the backbone, parallel to the spinal cord. The procedure permanently interrupts the nerve signal that is causing the body to sweat excessively.
Hyperhidrosis, or excessive sweating, is a medical condition that may be defined as sweating beyond a level that is necessary to maintain normal body temperature as it responds to environmental exposure or exercise. Hyperhidrosis is classified as primary or secondary depending on its cause.
Primary hyperhidrosis (essential or idiopathic) is caused by increased sympathetic nervous system activity, which can lead to excessive sweating. There are several types of primary hyperhidrosis, which affects specific locations of the body: facial sweating (craniofacial), facial blushing (erythrophobia), underarm sweating (axillary), hand sweating (palmar), foot sweating (plantar).
Secondary hyperhidrosis is a symptom of an underlying neurological or systemic disease (i.e. over-active thyroid, low blood sugar, or menopause) which usually affects the whole body. Secondary hyperhidrosis does not involve a malfunctioning sympathetic nervous system
If available, codes are listed below for informational purposes only, and do not guarantee member coverage or provider reimbursement. The list may not be all-inclusive.
Thoracoscopy, surgical; with thoracic sympathectomy
Excision of skin and subcutaneous tissue for hidradenitis, axillary; with simple or intermediate repair
Suction assisted lipectomy; trunk
Suction assisted lipectomy; upper extremity
ICD 10 Codes
Hyperhidrosis, primary, axilla
Hyperhidrosis, primary, palms
CPT Copyright American Medical Association. All rights reserved. CPT is a registered trademark of the American Medical Association.
This information is for most, but not all, HealthPartners plans. Please read your plan documents to see if your plan has limits or will not cover some items. If there is a difference between this general information and your plan documents, your plan documents will be used to determine your coverage. These coverage criteria may not apply to Medicare Products if Medicare requires different coverage. For more information regarding Medicare coverage criteria or for a copy of a Medicare coverage policy, contact Member Services at 952-883-7979 or 1-800-233-9645.
- Cerfolio, R., De Campos, J. Bryant, A., Connery, C. Miller, D. DeCamp, M. McKenna, R. and Krasna, M. (2011) The Society of Thoracic Surgeons Expert Consensus for the Surgical Treatment of Hyperhidrosis. Annals of Thoracic Surgery, 2011; 91: 1642-1648.
- Dickman, C. (2007, Reaffirmed 2009) American Association of Neurosurgeons – Sympathectomy for Hyperhidrosis Position Statement. Retrieved from https://www.aans.org/en/About-Us/Position-Statements
- ECRI Institute. (2013). Endoscopic Thoracic Sympathectomy for Treating Hyperhidrosis. Plymouth Meeting, PA: ECRI Institute.
- ECRI Institute. (2013). Iontophoresis of Treating Hyperhidrosis. Plymouth Meeting, PA: ECRI Institute.
- Glaser, D., Coleman, W., Fan, L., Kaminer, M., Kilmer, S., Nossa, R., Smith, S. and O’Shaughnessy, K. (2012) A Randomized, Blinded Clinical Evaluation of a Novel Microwave Device for Treating Axillary Hyperhidrosis: The Dermatologic Reduction in Underarm Perspiration Study. Dermatologic Surgery 2012; 38: 185-191.
- Hayes, Inc. Hayes Medical Technology Directory Report. Endoscopic Sympathectomy Treatment of Hyperhidrosis. Lansdale, PA: Hayes, Inc.; January, 2003. Reviewed February, 2008/Archived November, 2008.
- Hayes, Inc. Hayes Medical Technology Directory Report. Botulinum Toxin Treatment for Hyperhidrosis. Lansdale, PA: Hayes, Inc.; January, 2008. Reviewed January, 2012/Archived February, 2013.
- Hayes, Inc. Hayes Search and Summary Report. Liposuction for Hyperhidrosis. Lansdale, PA. Hayes, Inc. August, 2007.
- Hayes, Inc. Hayes Search and Summary Report. miraDry (Miramar Labs Inc) for the Treatment of Hyperhidrosis. Lansdale, PA. Hayes, Inc. April, 2017.
- Hong, H., Lupin, M. and O’Shaughnessy, K. (2012) Clinical Evaluation of a Microwave Device for Treating Axillary Hyperhidrosis. Dermatologic Surgery. 38(5): 728-735.
- Hoorens I. and Ongenae, K. (2012). Primary focal hyperhidrosis: current treatment options and a step-by-step approach. Journal of the European Academy of Dermatology and Venereology. 26(1): 1-8.
- Ibrahim, O., Kakar, R., Bolotin, D., Nodzenski, M., Disphanurat, W., Pace, N., Becker, L...and Alam, M. (2013). The comparative effectiveness of suction-currettage and onabotulinumtoxin-A injections for the treatment of primary focal axillary hyperhidrosis: A randomized control trial Capsule Summary. Journal of the American Academy of Dermatology. 69(1): 88-95.
- National Institute for Health and Care Excellence. (2014) Endoscopic thoracic sympathectomy for primary hyperhidrosis of the upper limb- Interventional Procedures Guidance. Retrieved on 6/15/2017 from https://www.nice.org.uk/guidance
- National Institute for Health and Care Excellence (2017) Trancutaneous microwave ablation for severe primary axillary hyperhidrosis- Interventional procedures guidance. Retrieved on 4/12/18 from https://www.nice.org.uk/guidance
- Ram, R., Lowe, N. and Yamauchi, P. (2007) Current and Emerging Therapeutic Modalities for Hyperhidrosis, part 1: Conservative and Non-invasive Treatments. Cutis 2007; 79(3): 211-217.
- Ram, R., Lowe, N. and Yamauchi, P. (2007) Current and Emerging Therapeutic Modalities for Hyperhidrosis, part 2: Moderately Invasive and Invasive Procedures. Cutis 2007; 79(4): 281-288.
- Reisfeld, R. and Berliner, K. (2008) Evidence-Based Review of the Nonsurgical Management of Hyperhidrosis. Thoracic Surgery Clinics. 18(2): 157-166.
- Smith, C. Primary focal hyperhidrosis. In: UpToDate, Dellavalle, R. and Dahl, M. (Ed), UpToDate, Waltham, MA. (Accessed on 4/24/19).
- Sternbach, J. and DeCamp, M. (2016). Targeting the Sympathetic Chain for Primary Hyperhidrosis. Thoracic Surgery Clinics. 26(4): 407-420.
- Vannucci, F. and Araújo, J.A. (2017) Thoracic sympathectomy for hyperhidrosis: from surgical indications to clinical results. Journal of Thoracic Disease. 2017 Apr; 9(Suppl 3): S178-S192.
- 04/09/2002 - Date of origin
- 07/01/2017 - Effective date
- Legal disclaimer
- Botulinum toxins: abobotulinumtoxinA (Dysport®), incobotulinumtoxinA (Xeomin®), onabotulinumtoxinA (Botox®) and rimabotulinumtoxinB (Myobloc®)
- Botulinum toxins: abobotulinumtoxinA (Dysport®), incobotulinumtoxinA (Xeomin®), onabotulinumtoxinA (Botox®), and rimabotulinumtoxinB (Myobloc®) – Minnesota Health Care Programs
- DME benefits grid